Quality of therapy in early ovarian cancer: results of the quality assurance program of the AGO Study Group.

Autor: Wimberger P; Gynecology and Obstetrics, Technische Universitat Dresden Medizinische Fakultat Carl Gustav Carus, Dresden, Germany pauline.wimberger@uniklinikum-dresden.de., Pfisterer J; Gynecologic Cancer Center, Kiel, Germany., du Bois A; Department of Gynecology and Gynecologic Oncology, Ev. Kliniken Essen-Mitte, Essen, Germany., Hilpert F; Oncologic Therapy Center Hospital Jerusalem, Hamburg, Germany., Kerkmann M; MMF GmbH, Münster, Germany., Sehouli J; Gynecology with Center of Oncological Surgery, Charité University Berlin, Berlin, Germany., Mahner S; Department of Gynecology and Obstetrics, Ludwig-Maximilians-University Munich, Munich, Germany., de Gregorio N; Klinikum am Gesundbrunnen, SLK-Kliniken Heilbronn GmbH, Heilbronn, Germany., Hanker L; University Hospital Schleswig-Holstein, University Hospital Schleswig-Holstein, Lubeck, Germany., Heitz F; Department of Gynecology and Gynecologic Oncology, Ev. Kliniken Essen-Mitte, Essen, Germany., Marmé F; Department of Gynecology, University Mannheim, Medical Faculty Mannheim of the University of Heidelberg, Mannheim, Germany., Woelber L; Department of Gynecology, University Medical Center Hamburg-Eppendorf, Hamburg, Germany., Holtmann L; MMF GmbH, Münster, Germany., Elser G; AGO Study Group Wiesbaden, Wiesbaden, Germany., Harter P; Department of Gynecology and Gynecologic Oncology, Ev. Kliniken Essen-Mitte, Essen, Germany.

Publikováno v: International journal of gynecological cancer : official journal of the International Gynecological Cancer Society [Int J Gynecol Cancer] 2023 Jul 03; Vol. 33 (7), pp. 1083-1089. Date of Electronic Publication: 2023 Jul 03.

A phase II study of paclitaxel, carboplatin, and gemcitabine in previously untreated patients with epithelial ovarian cancer FIGO stage IC–IV (AGO-OVAR protocol OVAR-8)

Autor: du Bois, A. ^*, Belau, A., Wagner, U., Pfisterer, J., Schmalfeldt, B., Richter, B., Staehle, A., Jackisch, C., Lueck, H.J., Schroeder, W., Burges, A., Olbricht, S., Elser, G.

Publikováno v: In Gynecologic Oncology 2005 96(2):444-451

Roadmap for the European Network of Gynaecological Trial groups (ENGOT) Trials

Autor: Vergote, I., Elser, G., Votan, B., Farrelly, L., Roover, J. De, Bryce, J., Bois, A. du, Penninckx, B., Campo, J. Del, Pujade-Lauraine, E., Bamias, A., Calvert, P., Colombo, N., Pignata, S., Ledermann, J.A., Sehouli, J., Kristensen, G., Siddiqui, N., Tulunay, G., Pfisterer, J., Marth, C., Mirza, M., Ottevanger, P.B., Casado, A.

Publikováno v: International Journal of Gynecological Cancer, 23, 1339-43
International Journal of Gynecological Cancer, 23, 7, pp. 1339-43

The European Network for Gynaecological Oncological Trial groups (ENGOT) is a research network of the European Society of Gynaecological Oncology and was founded in Berlin in October 2007. Earlier, we reported on the ENGOT minimal requirements for tr

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::503cd3f91f90d4ccb32c6ee08cd369ee
https://hdl.handle.net/2066/186688

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Prevalence of deleterious germline variants in risk genes including BRCA1/2 in consecutive ovarian cancer patients (AGO-TR-1).

Autor: Harter P; Department of Gynecology & Gynecologic Oncology, Kliniken Essen-Mitte, Essen, Germany., Hauke J; Center for Hereditary Breast and Ovarian Cancer, University Hospital Cologne, Medical Faculty, Cologne, Germany.; Center for Integrated Oncology (CIO), University Hospital Cologne, Medical Faculty, Cologne, Germany., Heitz F; Department of Gynecology & Gynecologic Oncology, Kliniken Essen-Mitte, Essen, Germany., Reuss A; Coordinating Center for Clinical Trials, Philipps-University of Marburg, Marburg, Germany., Kommoss S; Department of Women's Health, Tübingen University Hospital, Tübingen, Germany., Marmé F; National Center for Tumor Disease/Department of Gynecology, University of Heidelberg, Heidelberg, Germany., Heimbach A; Institute of Human Genetics, University of Bonn, Bonn, Germany., Prieske K; Department of Gynecology and Gynecologic Oncology, University Medical Center Hamburg-Eppendorf, Hamburg, Germany., Richters L; Center for Hereditary Breast and Ovarian Cancer, University Hospital Cologne, Medical Faculty, Cologne, Germany.; Center for Integrated Oncology (CIO), University Hospital Cologne, Medical Faculty, Cologne, Germany., Burges A; Department of Gynecology, University Hospital Munich-Großhadern. Munich, Germany., Neidhardt G; Center for Hereditary Breast and Ovarian Cancer, University Hospital Cologne, Medical Faculty, Cologne, Germany.; Center for Integrated Oncology (CIO), University Hospital Cologne, Medical Faculty, Cologne, Germany., de Gregorio N; Department of Gynecology, University of Ulm, Ulm, Germany., El-Balat A; Department of Gynecology, University of Frankfurt, Frankfurt, Germany., Hilpert F; Onkologisches Therapiezentrum, Krankenhaus Jerusalem, Hamburg, Germany/ Department of Gynecology, University of Kiel, Kiel, Germany.; Department of Gynecology, University of Kiel, Kiel, Germany., Meier W; Department of Gynecology, Evangelisches Krankenhaus, Duesseldorf, Germany., Kimmig R; Department of Gynecology, University of Essen, Essen, Germany., Kast K; Department of Gynecology and Obstetrics, Medical Faculty and University Hospital Carl Gustav Carus, Technische Universität Dresden, Dresden, Germany.; National Center for Tumor Diseases (NCT), Partner Site Dresden, Dresden, Germany.; German Cancer Consortium (DKTK), Dresden and German Cancer Research Center (DKFZ), Heidelberg, Germany., Sehouli J; Department of Gynecology and Gynecological Oncology, Charité, Campus Virchow, Berlin, Germany., Baumann K; Department of Gynecology and Obstetrics, Klinikum Ludwigshafen, Ludwigshafen, Germany.; Department of Gynecology, Gynecologic Endocrinology & Oncology, Philipps-University Marburg, Marburg, Germany., Jackisch C; Department of Gynecology and Obstetrics, Sana Klinikum, Offenbach, Germany., Park-Simon TW; Department of Gynecology, Medizinische Hochschule Hannover, Hannover, Germany., Hanker L; Department of Gynecology & Obstetrics, University Hospital Schleswig-Holstein, Campus Lübeck, Lübeck, Germany., Kröber S; Center for Hereditary Breast and Ovarian Cancer, University Hospital Cologne, Medical Faculty, Cologne, Germany.; Center for Integrated Oncology (CIO), University Hospital Cologne, Medical Faculty, Cologne, Germany., Pfisterer J; Center of Gynecological Oncology, Kiel, Germany., Gevensleben H; Institute of Pathology, University Hospital Bonn, Bonn, Germany., Schnelzer A; Department of Gynecology, Klinikum rechts der Isar, Technical University of Munich, Munich, Germany., Dietrich D; University Hospital Bonn, Department of Otolaryngology, Head and Neck Surgery, Bonn, Germany., Neunhöffer T; Department of Gynecology, Dr. Horst-Schmidt-Kliniken, Wiesbaden, Germany., Krockenberger M; Department of Gynecology, University of Würzburg, Würzburg, Germany., Brucker SY; Department of Women's Health, Tübingen University Hospital, Tübingen, Germany., Nürnberg P; Center for Molecular Medicine Cologne (CMMC), University of Cologne, Cologne, Germany.; Cologne Center for Genomics (CCG), University of Cologne, Cologne, Germany.; Cologne Excellence Cluster on Cellular Stress Responses in Aging-Associated Diseases (CECAD), University of Cologne, Cologne, Germany., Thiele H; Cologne Center for Genomics (CCG), University of Cologne, Cologne, Germany., Altmüller J; Center for Molecular Medicine Cologne (CMMC), University of Cologne, Cologne, Germany.; Cologne Center for Genomics (CCG), University of Cologne, Cologne, Germany., Lamla J; AGO Study Group, Wiesbaden, Germany., Elser G; AGO Study Group, Wiesbaden, Germany., du Bois A; Department of Gynecology & Gynecologic Oncology, Kliniken Essen-Mitte, Essen, Germany., Hahnen E; Center for Hereditary Breast and Ovarian Cancer, University Hospital Cologne, Medical Faculty, Cologne, Germany.; Center for Integrated Oncology (CIO), University Hospital Cologne, Medical Faculty, Cologne, Germany., Schmutzler R; Center for Hereditary Breast and Ovarian Cancer, University Hospital Cologne, Medical Faculty, Cologne, Germany.; Center for Integrated Oncology (CIO), University Hospital Cologne, Medical Faculty, Cologne, Germany.

Publikováno v: PloS one [PLoS One] 2017 Oct 20; Vol. 12 (10), pp. e0186043. Date of Electronic Publication: 2017 Oct 20 (Print Publication: 2017).